Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK S. Aureus Vaccine in Healthy Adults and Adults With SSTI
NCT04420221Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2022
- Primary completion
- Mar 2024
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of PentaStaph in Staphylococcus aureus skin and soft tissue infection, sponsored by GSK. Started Nov 2022; status: completed.
02
Drugs
PentaStaph
03
Conditions
Staphylococcus aureus skin and soft tissue infection
Beyond the preview
Go deeper on NCT04420221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420221.